Learn More
Medchemexpress LLC 2-amino-3-(2'-chloro-5-(phosphonomethyl)-[1,1'-biphenyl]-3-yl)propanoic acid | 174575-17-8 | 98.8% | C16H17ClNO5P | 10MG

Supplier: Medchemexpress LLC HY1305910MG
SDZ 220-581 is a potent, orally active, competitive NMDA receptor antagonist (reported pKi 7.7) provided for research use in neuroscience and pharmacology studies. The compound is supplied with analytical documentation and formulation options to support in vitro and in vivo experiments.
- Potent NMDA receptor antagonist (pKi 7.7).
- Orally active pharmacological profile suitable for in vivo studies.
- Competitive mode of action at NMDA receptors.
- Available as a solid and as a 10 mM solution in DMSO.
- High reported purity (≈98.8%).
- Provided with datasheet, COA, and SDS for quality assurance.
- Multiple package sizes to accommodate small-scale experiments.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.